🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Placebo on day 0, 28

Found 216 matching trials

Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

PHASE1

This study is a randomized, double-blinded, and placebo-controlled phase Ia...

Status

Completed

Location

West China Second University Hospital, Sichuan University / West China women's and children's Hospital

Start Date

2020-05-15

Trial ID

NCT04412538

Treatments Being Tested

Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule Placebo on a 0- and 28-day schedule Placebo on a 0- and 14-day schedule

Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis

PHASE1

The purpose of this study is to evaluate the pharmacodynamics, safety, and ...

Status

Withdrawn

Location

Multiple Locations

Start Date

2011-12

Trial ID

NCT01434576

Treatments Being Tested

HGS1025 HGS1025 Placebo

Phase II Clinical Trial of the Inactivated Rotavirus Vaccine

PHASE2

This study is a randomized, double-blinded, placebo-controlled phase 2 clin...

Status

Unknown

Location

Tongxu Center for Disease Prevention and Control

Start Date

2023-10-20

Trial ID

NCT06080906

Treatments Being Tested

IRV on a 0- and 28-day schedule IRV on a 0-, 28- and 56-day schedule Placebo on Day 0, 28 Placebo on Day 0, 28, 56

Repetitive Levosimendan Infusion for Patients With Advanced Chronic Heart Failure

PHASE3

Repetitive levosimendan infusions for patients with advanced chronic heart ...

Status

Unknown

Location

Medical University Innsbruck

Start Date

2018-03-08

Trial ID

NCT03437226

Treatments Being Tested

Levosimendan 2.5 MG/ML Placebos

Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers

PHASE1

The purpose of this study is to determine the safety and tolerability of a ...

Status

Completed

Location

Multiple Locations

Start Date

2005-07

Trial ID

NCT00127803

Treatments Being Tested

Placebo (vaccine diluent)Clostridium difficile vaccine Clostridium difficile vaccine Clostridium difficile vaccine

Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection

PHASE2

Primary objective: To compare the event rate of CDI in groups assigned to A...

Status

Completed

Location

Multiple Locations

Start Date

2009-02

Trial ID

NCT00772343

Treatments Being Tested

0.9% Normal Saline Clostridium difficile toxoid vaccine Clostridium difficile toxoid vaccine with adjuvant Clostridium difficile toxoid vaccine

A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation

PHASE2

The purpose of this study is to evaluate the effect of BMS-919373 on atrial...

Status

Terminated

Location

Cardiology Consultants Of Orange County Med. Group Inc

Start Date

2014-07-25

Trial ID

NCT02156076

Treatments Being Tested

BMS-919373 Placebo (Matching with BMS-919373)

Study of the Safety and Efficacy of Natural Genome Reconstruction Technology of Hematopoietic Stem Cells in Adult Patients

This pilot randomized, double-blind, placebo-controlled study evaluates the...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2025-09-01

Trial ID

NCT06877377

Treatments Being Tested

hDNAgr Therapy Placebo

A Study of Abatacept in Patients With Active Crohn's Disease

PHASE3

The purpose of this clinical research study is to learn if abatacept can im...

Status

Terminated

Location

University Of Alabama Medical Center

Start Date

2006-12

Trial ID

NCT00406653

Treatments Being Tested

abatacept placebo abatacept

Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59

PHASE1

This research will study safety and the body's immune (defense system) resp...

Status

Completed

Location

Emory Children's Center - Pediatric Infectious Diseases

Start Date

2010-06

Trial ID

NCT00912496

Treatments Being Tested

MF-59 A/Anhui/05 Placebo

Previous Next